SCHEMBL796250

SCHEMBL796250

FCCOc1ccc2c(c1)sc1nc(-c3ccc(-c4ccc(I)nn4)cc3)cn12

nearest known ligand 0.69

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
APP P05067 2/20 0.69
MAPT P10636 5/20 0.50
TP53 P04637 5/20 0.50
LMNA P02545 2/20 0.50
SMN1; SMN2 Q16637 2/20 0.50
TSHR P16473 1/20 0.50
RAB9A P51151 1/20 0.50
ATM Q13315 1/20 0.50
TDP1 Q9NUW8 1/20 0.50
RXFP1 Q9HBX9 1/20 0.43
FLT3 P36888 5/20 0.42
THRB P10828 1/20 0.42
KDM4E B2RXH2 1/20 0.41
ALDH1A1 P00352 1/20 0.41
BMPR1B O00238 1/20 0.41
MUSK O15146 1/20 0.41
EPHB6 O15197 1/20 0.41
MAP3K7 O43318 1/20 0.41
RIPK2 O43353 1/20 0.41
PAK3 O75914 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL796947 0.89 APP (0.76) APPMAPTTP53LMNASMN1; SMN2
SCHEMBL796974 0.88 APP (0.72) APPMAPTTP53LMNASMN1; SMN2
SCHEMBL1853165 0.86 APP (0.77) APPMAPTTP53LMNASMN1; SMN2
SCHEMBL796951 0.85 APP (0.70) APPMAPTTP53LMNASMN1; SMN2
SCHEMBL13290984 0.82 APP (0.75) APPMAPTTP53LMNASMN1; SMN2
SCHEMBL772879 0.82 APP (1.00) APPMAPTTP53LMNASMN1; SMN2
SCHEMBL1851914 0.82 APP (0.75) APPMAPTTP53LMNASMN1; SMN2
SCHEMBL796995 0.82 APP (1.00) APPMAPTTP53LMNASMN1; SMN2
SCHEMBL796023 0.81 APP (0.64) APPMAPTTP53LMNASMN1; SMN2
SCHEMBL796670 0.80 APP (0.69) APPMAPTTP53LMNASMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20120070374-A1 Compounds for Non-Invasive Measurement of Aggregates of Amyloid Peptides TECHNISCHE UNIVERSITAT MUNCHEN (DE) 2012-03-22 US disclosed
US-20120070374-A1 Compounds for Non-Invasive Measurement of Aggregates of Amyloid Peptides TECHNISCHE UNIVERSITAT MUNCHEN (DE) 2012-03-22 US disclosed
WO-2010092111-A2 COMPOUNDS FOR NON-INVASIVE MEASUREMENT OF AGGREGATES OF AMYLOID PEPTIDES Technische Universität München (DE) 2010-08-19 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120070374-A1 Compounds for Non-Invasive Measurement of Aggregates of Amyloid Peptides IAPP, APP, HTT APP 2/4885MAPT 10/4885TP53 619/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.